You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Thrombocytopenic Purpura

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

Recruiting
  • Immune Thrombocytopenia
  • Suzhou, Jiangsu, China
    Jie Yin
Apr 19, 2022

Immune Thrombocytopenia Trial in Sohag (Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR)

Not yet recruiting
  • Immune Thrombocytopenia
  • Genotyping of rs1980422-related single-nucleotide polymorphisms by real time PCR
  • Sohag, Egypt
    Sohag University Hospital
Jul 19, 2022

Primary Immunodeficiency Diseases (PID), Immune Thrombocytopenic Purpura (ITP), Kawasaki Syndrome Trial in United States (Immune

Completed
  • Primary Immunodeficiency Diseases (PID)
  • +2 more
  • Immune Globulin Intravenous (Human), 10%
  • Los Angeles, California
  • +10 more
Aug 22, 2021

Primary Immune Thrombocytopenia Trial in Guadalajara (Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet)

Completed
  • Primary Immune Thrombocytopenia
  • Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Sep 20, 2022

Idiopathic Thrombocytopenic Purpura Trial in Cairo (Eltrombopag, conventional)

Completed
  • Idiopathic Thrombocytopenic Purpura
  • Cairo, Egypt
    Ainshams University , Faculty of medicine , Pediatric Hematology
Oct 26, 2021

Immune Thrombocytopenia, Purpura, Thrombocytopenic Trial in Jinan (Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • Purpura, Thrombocytopenic
  • Atorvastatin 20mg
  • +2 more
  • Jinan, Shandong, China
    Qilu hospital, Shandong University
Aug 30, 2021

Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Bruton Tyrosine Kinase
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 6, 2022

Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 17, 2022

Functional Activity of Platelets for Differential Diagnosis of

Not yet recruiting
  • Immune Thrombocytopenia
  • +3 more
  • Flow cytometry
  • Platelet aggregation and plasma coagulation
  • (no location specified)
Dec 8, 2022

Immune Thrombocytopenia Trial in Houston (Acetaminophen and Diphenhydramine Only Product)

Recruiting
  • Immune Thrombocytopenia
  • Acetaminophen and Diphenhydramine Only Product
  • Houston, Texas
    Texas Children's Hospital
Apr 11, 2022

Immune Thrombocytopenia Trial in Beijing (Iguratimod)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 21, 2022

Caplacizumab in Treatment of Acquired Thrombotic

Not yet recruiting
  • Acquired Thrombotic Thrombocytopenic Purpura
  • Cologne, Germany
    University Hospital of Cologne
May 25, 2023

Idiopathic Thrombocytopenic Purpura Trial in Worldwide (Romiplostim)

Completed
Has Results
  • Idiopathic Thrombocytopenic Purpura
  • Romiplostim
  • Anaheim, California
  • +47 more
Sep 8, 2022

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
  • +9 more
Jul 11, 2023

Immune Thrombocytopenia Trial (Zanubrutinib, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
May 6, 2022

Primary Immune Thrombocytopenic Purpura Trial in Tianjin (HBM9161 Dose A, HBM9161 Dose B, Placebo)

Recruiting
  • Primary Immune Thrombocytopenic Purpura
  • HBM9161 Dose A
  • +2 more
  • Tianjin, Tianjin, China
    Hematology hospital, Chinese academy of medical sciences
Feb 9, 2021

Immune Thrombocytopenia, Blood Coagulation Disorders, Thrombocytopenia Trial in Beijing (Sitagliptin, Danazol)

Recruiting
  • Immune Thrombocytopenia
  • +3 more
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 25, 2022

Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG [Olumiant], Danazol)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
  • +9 more
May 2, 2023

Immune Thrombocytopenia Trial in Beijing (Zanubrutinib, Eltrombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
May 6, 2022

Immune Thrombocytopenia, Treatment Trial in Tianjin (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 19, 2022

Immune Thrombocytopenia, Autoimmune Hemolytic Anemia Trial in Toulouse (no specific intervention)

Recruiting
  • Immune Thrombocytopenia
  • Autoimmune Hemolytic Anemia
  • no specific intervention
  • Toulouse, France
    Service de Médecine Interne
Jan 24, 2022

Immune Thrombocytopenia Trial in Jena

Recruiting
  • Immune Thrombocytopenia
    • Jena, Germany
      University Hospital Jena
    Mar 29, 2022

    Primary Immune Thrombocytopenia (ITP) Trial (Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Combination of Rituximab with subcutaneous belimumab
    • Combination of Rituximab with subcutaneous placebo
    • (no location specified)
    Apr 15, 2022

    Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in France (data collection)

    Recruiting
    • Immune Thrombocytopenia
    • +2 more
    • data collection
    • Amiens, France
    • +8 more
    Jul 7, 2023

    Immune Thrombocytopenia Trial in Beijing (Orelabrutinib)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Beijing, Beijing, China
      Peking University Institute of Hematology
    Nov 6, 2021